Angela is a member of the Practice Area Patents Technology & Life Sciences and the Industry Group Life Sciences & Healthcare. She advises national and international pharmaceutical and medical device companies on all aspects of health law.
One of her main areas of practice is litigation and dispute resolution of competition law complaints (enforcement and defence) in both drug advertising and medical device law. Another focus of her practice is the review of marketing materials and campaigns in terms of drug advertising law. In addition, she provides regulatory advice with regard to the manufacture, labelling and marketing of medicinal products, medical devices, dietary supplements, cosmetics, biocides and chemicals.
|Since 2020||Senior Associate, Taylor Wessing|
|2019 – 2020||Associate, Taylor Wessing|
|2020||Lecturer for Regulatory Affairs/Digital Health Management, Aalen University|
|2017 – 2019||Associate, a law firm specialized in Life Sciences & Healthcare, Duesseldorf|
|2017||Ph.D., University of Heidelberg|
|2017||Admitted to the Bar|
|2016||Second Bar Examination, Higher Regional Court of Duesseldorf|
|2014 – 2016||Legal clerkship, Regional Court of Duesseldorf|
|2014||Scientific Assistant at a law firm specialized in medical criminal law and white collar crime, Duesseldorf|
|2012||First Bar Examination, University of Heidelberg|
|2006 – 2012||Legal studies, University of Heidelberg|
Health apps on prescription – start for digital health apps, in: Medizinprodukte Journal, 03/2020, p. 207 (with Dr. Nicolai Wiegand)
Patents and approvals – medicines, vaccines and diagnostics for COVID-19, in: European Pharmaceutical Review, 03/2020, p. 24 (with Paul England, Dr. Anja Lunze, Jan Phillip Rektorschek and Alison Dennis)
Pharmaceutical Patent Law in Times of Crisis: A Comparative Study Part II, in: European Intellectual Property Review Volume 42, Issue 10, 2020, p. 643 (with David Mulder, Christian Dekoninck, Adrian Toutoungi, Matthew Caskie, Dr. Anja Lunze, Barbora Dubanská und Dr. Agnieszka Sztoldman)
The reimbursability of therapeutic allergens in the approval process, in: PharmR, 02/2020, p. 61
Annotation on the German Medicinal Products Act, Zuck/Dettling, with Dr. Alexander Natz, 2019
Annotation on the judgment of the Federal Social Court of 30 November 2017, ref.: B 3 KR 3/16 R and on the judgment of the Regional Social Court of Berlin-Brandenburg of 22 February 2018, fef.: L 1 KR 56/14
Duncker & Humblot 06/2018: Dissertation: The element of crime "demand" in criminal law. At the same time a contribution to theories on legal wrong exemplified by the death on demand and the termination of pregnancy after conflict consulting.
GRUR-Prax 06/2017: Article: Cooperation of online pharmacies with internet plat-forms is impermissible – Annotation on Higher Regional Court of Cologne, judgement of 22 February 2017 – 6 U 101/16 (with Dr. Christian Stallberg), p. 267
GRUR-Prax 03/2017: Article: Federal Court of Justice: Obligation of the distributor to indicate contact data of manufacturer – "Motivkontaktlinsen" – Annotation on Federal Court of Justice, judgement of 12 January 2017 – I ZR 258/15 (with Dr. Christian Stallberg), p. 130